3.0.0 3250 2023-01-11T13:30:24Z 2023-01-11T13:30:24Z House HR 2015-07-28 114 [Congressional Record Volume 161, Number 120 (Tuesday, July 28, 2015)]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. JOHNSON of Ohio:H.R. 3250.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 1 of the United StatesConstitution[Page H5590]]]> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Reported by 2016-04-20T13:19:01Z Markup by 2016-04-20T13:18:46Z Referred to 2015-07-31T20:50:21Z Reported by 2016-07-08T17:04:19Z Markup by 2016-04-27T19:54:39Z Referred to 2015-07-28T14:04:50Z H. Rept. 114-672 DXM Abuse Prevention Act of 2016 114 2994 S 2016-05-26 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Related bill CRS 2016-07-08 Placed on the Union Calendar, Calendar No. 520. Calendars H12410 2 House floor actions U00520 2016-07-08 Reported by the Committee on Energy and Commerce. H. Rept. 114-672. Committee H12200 2 House floor actions hsif00 Energy and Commerce Committee 2016-07-08 Reported by the Committee on Energy and Commerce. H. Rept. 114-672. Committee 5000 9 Library of Congress hsif00 Energy and Commerce Committee 2016-04-27 hsif00 Energy and Commerce Committee 1 House committee actions Ordered to be Reported by Voice Vote. Committee 2016-04-27 hsif00 Energy and Commerce Committee 1 House committee actions Committee Consideration and Mark-up Session Held. Committee 2016-04-26 hsif00 Energy and Commerce Committee 1 House committee actions Committee Consideration and Mark-up Session Held. Committee 2016-04-25 hsif00 Energy and Commerce Committee 1 House committee actions Committee Consideration and Mark-up Session Held. Committee 2016-04-20 hsif14 Health Subcommittee 1 House committee actions Forwarded by Subcommittee to Full Committee by Voice Vote . Committee 2016-04-20 hsif14 Health Subcommittee 1 House committee actions Subcommittee Consideration and Mark-up Session Held. Committee 2015-07-31 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2015-07-28 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2015-07-28 Introduced in House IntroReferral Intro-H 9 Library of Congress 2015-07-28 Introduced in House IntroReferral 1000 9 Library of Congress J000292 Rep. Johnson, Bill [R-OH-6] Bill Johnson R OH 6 N M001163 Rep. Matsui, Doris O. [D-CA-6] Doris Matsui D CA O. 6 2015-07-28 True L000565 Rep. Loebsack, David [D-IA-2] David Loebsack D IA 2 2015-09-10 False T000469 Rep. Tonko, Paul [D-NY-20] Paul Tonko D NY 20 2015-09-28 False B001248 Rep. Burgess, Michael C. [R-TX-26] Michael Burgess R TX C. 26 2015-10-27 False G000558 Rep. Guthrie, Brett [R-KY-2] Brett Guthrie R KY 2 2015-10-27 False K000378 Rep. Kinzinger, Adam [R-IL-16] Adam Kinzinger R IL 16 2015-11-17 False B001269 Rep. Barletta, Lou [R-PA-11] Lou Barletta R PA 11 2015-11-17 False B001285 Rep. Brownley, Julia [D-CA-26] Julia Brownley D CA 26 2015-11-30 False C001067 Rep. Clarke, Yvette D. [D-NY-9] Yvette Clarke D NY D. 9 2016-01-05 False N000147 Del. Norton, Eleanor Holmes [D-DC-At Large] ELEANOR NORTON D DC HOLMES 0 2016-02-12 False H001068 Rep. Huffman, Jared [D-CA-2] Jared Huffman D CA 2 2016-02-26 False K000386 Rep. Katko, John [R-NY-24] John Katko R NY 24 2016-02-26 False O000168 Rep. Olson, Pete [R-TX-22] Pete Olson R TX 22 2016-04-12 False H000324 Rep. Hastings, Alcee L. [D-FL-20] ALCEE HASTINGS D FL L. 20 2016-04-12 False K000188 Rep. Kind, Ron [D-WI-3] RON KIND D WI 3 2016-04-28 False P000594 Rep. Paulsen, Erik [R-MN-3] Erik Paulsen R MN 3 2016-05-11 False C001106 Rep. Costello, Ryan A. [R-PA-6] Ryan Costello R PA A. 6 2016-06-28 False M001181 Rep. Meehan, Patrick [R-PA-7] Patrick Meehan R PA 7 2016-06-28 False D000623 Rep. DeSaulnier, Mark [D-CA-11] Mark DeSaulnier D CA 11 2016-07-06 False F000451 Rep. Fitzpatrick, Michael G. [R-PA-8] Michael Fitzpatrick R PA G. 8 2016-07-06 False 2016-06-28T11:58:00Z H.R. 3250, DXM Abuse Prevention Act of 2015 https://www.cbo.gov/publication/51720 As ordered reported by the House Committee on Energy and Commerce on April 27, 2016 Health Child health Civil actions and liability Drug safety, medical device, and laboratory regulation Drug trafficking and controlled substances Drug, alcohol, tobacco use Licensing and registrations Prescription drugs Retail and wholesale trades Health 00 2015-07-28 Introduced in House 2016-01-04T17:04:11Z DXM Abuse Prevention Act of 2015

This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale of a drug containing dextromethorphan (DXM) to an individual under age 18 unless the individual has a prescription or is actively enrolled in the military. Civil monetary penalties that escalate upon repeated violation are imposed.

To possess or receive unfinished DXM, a person must be registered with the Department of Health and Human Services as a producer of a drug or medical device or otherwise allowed to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients. Unfinished DXM may be distributed only to these authorized persons. Common carriers distributing unfinished DXM between authorized persons are exempted. Civil monetary penalties are imposed for possession and distribution violations.

]]>

79 2016-07-08 Reported to House without amendment 2016-07-19T18:28:15Z (This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

DXM Abuse Prevention Act of 2015

(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale of a drug containing dextromethorphan (DXM, a cough suppressant and drug of abuse) to an individual under age 18 unless the individual has a prescription or is actively enrolled in the military. Retailers selling DXM must implement a verification system to ensure compliance. Civil monetary penalties that escalate upon repeated violation are imposed.

(Sec. 3) Unfinished DXM may only be possessed by, distributed to, and received by persons registered with the Food and Drug Administration as producers of a drug or medical device or otherwise allowed to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients. Common carriers distributing unfinished DXM between authorized persons are exempted. Civil monetary penalties are imposed for possession and distribution violations.

]]>

DXM Abuse Prevention Act of 2015 Display Title DXM Abuse Prevention Act of 2015 Official Title as Introduced To amend the Federal Food, Drug, and Cosmetic Act to prevent the abuse of dextromethorphan, and for other purposes. Introduced in House IH Short Titles as Introduced DXM Abuse Prevention Act of 2015 Short Titles as Reported to House DXM Abuse Prevention Act of 2015 H House Reported in House 2016-07-08T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-114hr3250rh/xml/BILLS-114hr3250rh.xml Introduced in House 2015-07-28T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-114hr3250ih/xml/BILLS-114hr3250ih.xml 2016-07-08 Placed on the Union Calendar, Calendar No. 520. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.